Gracell Biotechnologies Inc. (GRCL) NASDAQ

$10.25 - (-)

Market Cap: -

As of 02/21/24 12:00 AM EST. Market closed.

(GRCL)

Gracell Biotechnologies Inc. (GRCL)
NASDAQ

$10.25
- (-)

Market Cap: -

As of 02/21/24 12:00 AM EST. Market closed.

Add to Portfolio

gracell biotechnologies inc. is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. leveraging its pioneering fastcar and truucar technology platforms, gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist ... read more

gracell biotechnologies inc. is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. leveraging its pioneering fastcar and truucar technology platforms, gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional car-t therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective car-t therapies for solid tumors. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Address
.
PRICE CHART FOR GRACELL BIOTECHNOLOGIES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$10.25
Days Range
- - -
52 week range
- - -
Volume
6,417,173
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
96,712,353
Open
-
Previous Close
$10.25
Days Range
- - -
52 week range
- - -
Volume
6,417,173
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
96,712,353
FINANCIAL STATEMENTS FOR GRACELL BIOTECHNOLOGIES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

FUNDS WITH A POSITION IN GRACELL BIOTECHNOLOGIES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC9,546,4857.85%-12.27%Other
ORBIMED ADVISORS LLC9,308,7261.87%No changeOther
BAKER BROS. ADVISORS LP2,080,0000.24%108%Other
PENTWATER CAPITAL MANAGEMENT LP1,461,0000.16%NewEvent Driven
ADAGE CAPITAL PARTNERS GP, L.L.C.1,350,0000.03%58.82%Other
TIG ADVISORS, LLC1,279,5951.6%NewEvent Driven
BLACKROCK INC.539,9730.00014%-3.48%Other
HARVEST MANAGEMENT LLC400,0003.71%NewEvent Driven
AQR ARBITRAGE LLC130,7790.05%NewEvent Driven
GEODE CAPITAL MANAGEMENT, LLC43,3340.00005%No changeOther
GABELLI FUNDS LLC39,8500.00308%NewEvent Driven, Growth, Activists
RENAISSANCE TECHNOLOGIES LLC39,3000.00061%-15.67%Other
BALYASNY ASSET MANAGEMENT L.P.20,1820.00038%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR GRACELL BIOTECHNOLOGIES INC
STOCK BUYBACKS FOR GRACELL BIOTECHNOLOGIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2023
03/31/2023
0.43%
1Q

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2023
0.43%
1Q
BUYBACK ANNOUNCEMENT(S) FOR GRACELL BIOTECHNOLOGIES INC
LOADING...